Linezolid
NDC 67877-419, Linezolid, tablet, film coated, from Ascend Laboratories, LLC.
- Product NDC
- 67877-419
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205517
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-419 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LINEZOLID600 mg/1
Pharmacologic classes
Oxazolidinone Antibacterial [EPC]; Oxazolidinones [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-419-01 | 67877041901 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-419-01) |
| 67877-419-05 | 67877041905 | 500 TABLET, FILM COATED in 1 BOTTLE (67877-419-05) |
| 67877-419-10 | 67877041910 | 1000 TABLET, FILM COATED in 1 BOTTLE (67877-419-10) |
| 67877-419-20 | 67877041920 | 20 TABLET, FILM COATED in 1 BOTTLE (67877-419-20) |
| 67877-419-33 | 67877041933 | 1 BLISTER PACK in 1 CARTON (67877-419-33) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| 67877-419-38 | 67877041938 | 10 BLISTER PACK in 1 CARTON (67877-419-38) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| 67877-419-84 | 67877041984 | 3 BLISTER PACK in 1 CARTON (67877-419-84) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| 67877-419-85 | 67877041985 | 2 BLISTER PACK in 1 CARTON (67877-419-85) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7402aa01-50de-46c8-a341-d30da5b32b1cNADAC price for package 67877041920
GET /v1/drugs/nadac/67877041920NADAC price for package 67877041933
GET /v1/drugs/nadac/67877041933NADAC price for package 67877041984
GET /v1/drugs/nadac/67877041984
Use it
Look up 67877-419 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-419 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-419. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.